Given the fact that several high-efficiency systems for delivering genes-of-interest into target histocytes and tumor cells were developed or in clinical trials35, 36, this tumor suppressor enhancing module is of high significance as it could be therapeutically exploited in clinic by ectopically expressing GATA4 in HCC tissues. This evidence concerns the gene GATA4 and hepatocellular carcinoma.